ConvaTec Group (LON:CTEC) Given Add Rating at Peel Hunt

ConvaTec Group (LON:CTEC)‘s stock had its “add” rating reissued by stock analysts at Peel Hunt in a note issued to investors on Thursday,Digital Look reports. They presently have a GBX 270 price target on the stock. Peel Hunt’s target price suggests a potential upside of 7.52% from the stock’s previous close.

CTEC has been the subject of several other research reports. Royal Bank Of Canada upgraded ConvaTec Group to an “outperform” rating and cut their price objective for the stock from GBX 320 to GBX 315 in a research report on Thursday, August 21st. UBS Group reiterated a “buy” rating and issued a GBX 375 price target on shares of ConvaTec Group in a report on Friday, November 7th. Berenberg Bank decreased their price objective on shares of ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating on the stock in a report on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. reiterated an “overweight” rating on shares of ConvaTec Group in a research report on Wednesday, July 30th. Six analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of GBX 318.67.

ConvaTec Group Trading Up 6.1%

Shares of ConvaTec Group stock opened at GBX 251.12 on Thursday. The firm has a market cap of £4.98 billion, a price-to-earnings ratio of 23.69, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64. ConvaTec Group has a 52-week low of GBX 218 and a 52-week high of GBX 311.20. The company’s 50-day simple moving average is GBX 238.17 and its 200-day simple moving average is GBX 252.40. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32.

Insider Buying and Selling

In other news, insider Jonny Mason bought 50,000 shares of the business’s stock in a transaction that occurred on Thursday, August 28th. The stock was purchased at an average price of GBX 235 per share, with a total value of £117,500. Corporate insiders own 0.94% of the company’s stock.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.